BackITeos Therapeutics Overview

ITeos Therapeutics Long Term Debt

Latest long-term debt for ITOS: $3.6M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$3.61M

Peer trimmed avg / median

Loading

ITeos Therapeutics Long Term Debt History

Loading

ITeos Therapeutics vs. peers: Long Term Debt Comparison

Loading

ITeos Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ITeos Therapeutics (ITOS) FAQ

ITeos Therapeutics (ITOS) currently reports a long-term debt of $3.6M as of June 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore ITeos Therapeutics's long-term debt history and peer comparisons.

ITeos Therapeutics's long-term debt changed from $0 to $3.6M (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ITeos Therapeutics reported $3.6M in long-term debt as of June 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $3.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ITeos Therapeutics, and consider following ITOS for alerts when major investors trade the stock.

ITeos Therapeutics is classified in the Healthcare sector. On long-term debt, it currently shows $3.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ITOS with unrelated industries.